Use Case

Asset Screening

Streamline business development and licensing strategies with solutions that provide actionable insights and inform decision making.

Identifying the right assets early is increasingly complex in a crowded and competitive market

Use Evaluate to uncover emerging trends, find assets that strengthen your pipeline, and understand where your drug and asset portfolios stand compared to the competition. Stay ahead of market changes and grasp their impact on both your business and your competitors.

Make your next move the right move

Get tailored guidance for this use case

Our experts can help you turn this use case into actionable strategy

Benchmark internal forecasts with consensus forecasts

Create a target list to screen for potential assets and identify candidates for in-licencing and acquisition that fit your specific area. Determine which assets have positive readouts versus those that raise red flags. Cross-check your internal view with the industry’s trusted consensus forecast, ensuring all relevant data sources are considered and evaluated.

 

Build and inform your investment strategy

Conduct a detailed market analysis, understand macrotrends, compare specific companies, and explore emerging spaces. Search for companies that are ready for funding or acquisition, identify risks, and evaluate potential assets earlier in the screening process with a single view of R&D risk and return.

 

Focus on specific business questions

Use our NPV Analyzer to track potential assets and project sales, peak revenue times, and costs. Recognize risks, strengths, weaknesses, and areas for improvement so you can form actionable recommendations from the analysis for both internal and external reporting.

 

Accurate asset screening to answer key business questions

Benchmark internal forecasts with consensus forecasts

Create a target list to screen for potential assets and identify candidates for in-licencing and acquisition that fit your specific area. Determine which assets have positive readouts versus those that raise red flags. Cross-check your internal view with the industry’s trusted consensus forecast, ensuring all relevant data sources are considered and evaluated.

  • Benchmark internal forecasts with consensus forecasts
  • Make accurate predictions of product-level risk, costs, and timelines

Focus on specific business questions

Use our NPV Analyzer to track potential assets and project sales, peak revenue times, and costs. Recognize risks, strengths, weaknesses, and areas for improvement so you can form actionable recommendations from the analysis for both internal and external reporting.

  • Uncover potential risks, strengths, weaknesses, and opportunities for  improvement
  • Identify projected sales, peak times for revenues, and costs

Build and inform your investment strategy

Conduct a detailed market analysis, understand macrotrends, compare specific companies, and explore emerging spaces. Search for companies that are ready for funding or acquisition, identify risks, and evaluate potential assets earlier in the screening process with a single view of R&D risk and return.

  • Evaluate potential assets earlier with a single view of R&D risk and return
  • Identify candidates for in-licensing and acquisition that fit your specific area
Get tailored guidance for this use case

Our experts can help you turn this use case into actionable strategy

Explore More Use Cases

Ready to see how Evaluate can help you make smarter decisions?

Get in touch with our team to explore the right solutions for your business.